A previous study reported reduced glucagon suppression in individuals with CF and glucose intolerance during an oral glucose tolerance test (OGTT) (12), suggesting that functions of other islet cell types are also affected by the CFRD pathology. This evidence concerns the gene GCG and cystic fibrosis.